Thorac Cardiovasc Surg
DOI: 10.1055/s-0040-1718773
Original Cardiovascular

First Experiences with MANTA Vascular Closure Device in Minimally Invasive Valve Surgery

Ali El-Sayed Ahmad
1  Division of Cardiac Surgery, Heart Centre Siegburg–Wuppertal, University Witten–Herdecke, Siegburg, Germany
,
Saad Salamate
1  Division of Cardiac Surgery, Heart Centre Siegburg–Wuppertal, University Witten–Herdecke, Siegburg, Germany
,
Mohamed Amer
1  Division of Cardiac Surgery, Heart Centre Siegburg–Wuppertal, University Witten–Herdecke, Siegburg, Germany
,
Sami Sirat
1  Division of Cardiac Surgery, Heart Centre Siegburg–Wuppertal, University Witten–Herdecke, Siegburg, Germany
,
Nadejda Monsefi
1  Division of Cardiac Surgery, Heart Centre Siegburg–Wuppertal, University Witten–Herdecke, Siegburg, Germany
,
Farhad Bakhtiary
1  Division of Cardiac Surgery, Heart Centre Siegburg–Wuppertal, University Witten–Herdecke, Siegburg, Germany
› Author Affiliations

Abstract

Background To more minimize the minimally invasive valve surgeries, percutaneous vascular access and closure has been used for the establishment of extracorporeal circulation. This study investigates early clinical outcomes of patients who received MANTA for femoral artery closure as first experiences in minimally invasive valve surgery.

Methods Between January 2019 and July 2019, 103 consecutive patients (mean age: 58 ± 11 years) underwent video-assisted minimally invasive valve surgery through right anterior minithoracotomy at two cardiac surgery referral centers in Germany. Percutaneous cannulation for cardiopulmonary bypass and femoral artery closure with MANTA were performed in all patients: 18-F and 14-F MANTA were used in 88 (85.4%) and 15 (14.6%) patient, respectively. Mitral, aortic, tricuspid, and double valve surgeries were performed in 51 (49.5%), 39 (37.9%), 7 (6.8%), and 6 (5.8%), patients, respectively. Clinical data were prospectively entered into our institutional database.

Results Cardiopulmonary bypass time and cross-clamping time were 69 ± 23 and 38 ± 14 minutes, respectively. Except for two patients with late pseudoaneurysm on 15th and 23th postoperative day, neither major nor minor vascular complications nor vascular closure device failure according to the Valve Academic Research Consortium-2 definition criteria was observed. Additionally, no wound healing disorders or conversion to surgical closure was observed.

Conclusions MANTA as percutaneous femoral artery closure after decannulation of cardiopulmonary bypass is a safe, feasible, and effective approach and yields excellent early outcomes. Larger size studies are needed to evaluate more the efficacy and safety of MANTA.

Disclaimer

The German Society for Thoracic and Cardiovascular Surgery (DGTHG) and the Thoracic and Cardiovascular Surgeon neither endorse nor discourage the use of the product described in this publication.




Publication History

Received: 17 April 2020

Accepted: 28 August 2020

Publication Date:
20 November 2020 (online)

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany